Please Enable Cookies

www.laserfocusworld.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year

Some patients with obstructive sleep apnea and obesity who took the highest dose of Zepbound achieved "disease resolution," in the two trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.